These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7659801)

  • 1. [Use of GnRH analogs in hysteroscopic surgery].
    Celis R
    Rev Chil Obstet Ginecol; 1994; 59(2):153-7. PubMed ID: 7659801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
    J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of uterine fibroids with GnRH-analogues prior to hysterectomy.
    Stjernquist M
    Acta Obstet Gynecol Scand Suppl; 1997; 164():94-7. PubMed ID: 9225649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit of GnRH analogue pretreatment for hysteroscopic surgery in patients with bleeding disorders.
    Römer T
    Gynecol Obstet Invest; 1998; 45 Suppl 1():12-20; discussion 21, 35. PubMed ID: 9628520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hysteroscopic endometrial ablation using the rollerball electrode.
    Daniell JF; Kurtz BR; Ke RW
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):329-32. PubMed ID: 1495687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GnRH agonist analogs and hysteroscopic resection of myomas.
    Mencaglia L; Tantini C
    Int J Gynaecol Obstet; 1993 Dec; 43(3):285-8. PubMed ID: 7907039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological preparation of the endometrium in surgical hysteroscopy].
    Primiero FM; Niccoli VS; Papale S
    Clin Ter; 1996 May; 147(5):245-51. PubMed ID: 8766356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial.
    Coddington CC; Grow DR; Ahmed MS; Toner JP; Cook E; Diamond MP
    Fertil Steril; 2009 May; 91(5):1909-13. PubMed ID: 18439584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [GnRH agonists and antagonists in the preoperative therapy of uterine fibroids: literature review].
    De Falco M; Pollio F; Pontillo M; Ambrosino E; Busiello A; Carbone IF; Ciociola F; Di Nardo MA; Landi L; Di Lieto A
    Minerva Ginecol; 2006 Dec; 58(6):553-60. PubMed ID: 17108883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of GnGH (GnRH-A) in gynecology].
    Ciardo A; Spina V; Aleandri V
    Minerva Ginecol; 1998; 50(1-2):25-9. PubMed ID: 9577152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [LH-RH analogues in the preparation of hysteroscopic resection of uterine fibromyoma].
    Pace S; Labi FL; Lotti G; Mastrone M; Grassi A
    Minerva Ginecol; 1992 May; 44(5):245-50. PubMed ID: 1608522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term and long-term results of resectoscopic myomectomy with and without pretreatment with GnRH analogs in premenopausal women.
    Campo S; Campo V; Gambadauro P
    Acta Obstet Gynecol Scand; 2005 Aug; 84(8):756-60. PubMed ID: 16026401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal inhibition of the endometrium for resectoscopic endometrial ablation.
    Brooks PG; Serden SP; Davos I
    Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1601-6; discussion 1606-8. PubMed ID: 1904683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of hysteroscopic myomectomy].
    Cravello L; Agostini A; Beerli M; Roger V; Bretelle F; Blanc B
    Gynecol Obstet Fertil; 2004 Sep; 32(9):825-8. PubMed ID: 15380769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial.
    Mavrelos D; Ben-Nagi J; Davies A; Lee C; Salim R; Jurkovic D
    Hum Reprod; 2010 Sep; 25(9):2264-9. PubMed ID: 20663795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative factors for predicting successful hysteroscopic endometrial ablation.
    Gemer O; Kapustian V; Kroll D; Tur-Kaspa I; Segal S
    J Reprod Med; 2003 Sep; 48(9):677-80. PubMed ID: 14562630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative use of GnRH agonist for leiomyomas.
    Hutchins FL
    J Reprod Med; 1997 Apr; 42(4):253. PubMed ID: 9131502
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas.
    Saltiel E
    Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin-releasing hormone agonist use before hysterectomy.
    Stovall TG; Summit RL; Washburn SA; Ling FW
    Am J Obstet Gynecol; 1994 Jun; 170(6):1744-8; discussion 1748-51. PubMed ID: 8203435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shrinkage effect of gonadotropin releasing hormone agonist treatment on uterine leiomyomas and t(12;14).
    Takahashi K; Kawamura N; Ishiko O; Ogita S
    Int J Oncol; 2002 Feb; 20(2):279-83. PubMed ID: 11788889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.